Buy Tesamorelin 5mg research peptide UK — the only full-length 44-amino acid GHRH analogue with N-terminal trans-3-hexenoic acid stabilisation. Pilot format for GHRH receptor research. ≥98% purity. Janoshik tested. Same-day UK dispatch before 4pm. Research use only.
Safety Information: Not intended for human or veterinary use. Use appropriate laboratory safety procedures when handling.
TESAMORELIN 5mg should only be used in laboratory settings by qualified personnel.
Ensure all experimental procedures comply with local and institutional regulations.
This peptide is supplied for research and scientific study purposes only
Research use only • UK dispatch • Orders before 4pm ship same day • Secure checkout
Buy Tesamorelin 5mg Research Peptide UK
Tesamorelin 5mg is a full-length GHRH research analogue commercially available for UK laboratory research. It replicates all 44 amino acids of native Growth Hormone Releasing Hormone and adds an N-terminal trans-3-hexenoic acid modification for enhanced DPP-IV resistance. Molecular formula C221H366N72O67S, molecular weight approximately 5,135.94 Da. This full-length sequence is the defining scientific characteristic that distinguishes it from every other GHRH research peptide.
While CJC-1295 Without DAC 10mg, CJC-1295 With DAC 10mg, and Sermorelin 2mg all use only the first 29 amino acids of native GHRH, the tesamorelin 5mg research peptide engages the complete 44-amino acid GHRH receptor binding interface. This makes it the appropriate compound for research requiring complete receptor contact surface engagement, structure-function studies comparing full-length versus truncated GHRH analogues, or protocols where physiological accuracy of receptor binding is the specific experimental variable rather than DPP-IV resistance or half-life characteristics.
The 5mg format is appropriate for pilot investigations, method development, assay validation, and first-time tesamorelin research. For established programmes requiring extended single-batch consistency and full dose-response gradients, Tesamorelin 10mg provides the advanced format. For comparative GHRH receptor research studying the truncated 29-amino acid analogues alongside the full-length sequence, CJC-1295 without DAC 10mg and Sermorelin 2mg are the appropriate complementary compounds. For GHRP complement in combined pulsatile protocols, Ipamorelin 5mg targets GHS-R1a independently of the GHRHR pathway.
Complete mechanism detail, pharmacokinetic data for the full 44-amino acid sequence, and comparison tables across all GHRH analogues are available in the buy tesamorelin 5mg research guide on the Ascend Peptides UK blog.
All tesamorelin 5mg batches are independently tested by Janoshik. HPLC purity confirmed at greater than or equal to 98%, with LC-MS confirming molecular identity and N-terminal modification.
For laboratory handling purposes, the lyophilised material may be reconstituted using bacteriostatic water or another suitable buffered aqueous solution depending on analytical protocol requirements. Store lyophilised material at -20°C and avoid repeated freeze-thaw cycles.
WADA Status: Prohibited at all times.
DISCLAIMER: For in-vitro research only. Not an MHRA-licensed medicine.
A curated entry point for buyers comparing quality, documentation, and availability.
UK same-day dispatch – PCI-
compliant payments –
Laboratory research only
© 2026 by Ascend Peptides Uk.
